Solventum Names Parag Kachalia Global Clinical Evidence Director
-
By
-
News Staff
-
September 28, 2026
Clinical Report: Solventum Names Parag Kachalia Global Clinical Evidence Director
Overview
Parag Kachalia, DDS, has been appointed as the global clinical evidence director at Solventum, focusing on clinical evidence strategy for digital dental solutions. He has 25 years of experience.
Background
The appointment of a global clinical evidence director reflects the growing importance of clinical evidence in the development of digital dental solutions. Kachalia's background in clinical practice and academia positions him to lead initiatives in dentistry.
Data Highlights
No numerical or trial data available in the source material.
Key Findings
- Parag Kachalia has joined Solventum as global clinical evidence director.
- Kachalia has 25 years of experience in clinical practice, academia, and dental technology.
- He previously served as head of clinical practice at Overjet and chief clinical officer of Seattle Study Club.
- Kachalia held a tenured faculty position at the University of the Pacific, Arthur A. Dugoni School of Dentistry.
- His role will focus on developing digital workflows to support diagnostic accuracy.
Clinical Implications
The appointment of Kachalia may influence the strategic direction of digital dental solutions at Solventum.
Conclusion
Parag Kachalia's appointment as global clinical evidence director at Solventum signifies a commitment to advancing clinical evidence strategies in digital dentistry.
Related Resources & Content
- the medicine maker, Solvents: Making the Green Choice, 2020 -- Solvents: Making the Green Choice
- the medicine maker, Formulation Best Practice, 2017 -- Formulation Best Practice
- the medicine maker, Building Better Oral Suspensions for Pediatric & Real-World Use, 2026 -- Building Better Oral Suspensions for Pediatric & Real-World Use
- American Dental Association, New ADA recommendations confirm dental imaging most effectively used in moderation, 2026 -- New ADA recommendations confirm dental imaging most effectively used in moderation
- PMC, Artificial intelligence for binary dental caries diagnosis using intraoral images and dental radiographs: a systematic review and meta-analysis, 2026 -- Artificial intelligence for binary dental caries diagnosis using intraoral images and dental radiographs: a systematic review and meta-analysis
- FDA, Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions, 2025 -- Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions
- the medicine maker — Weathering the Storm Together - Part 2
- New ADA recommendations confirm dental imaging most effectively used in moderation | American Dental Association
- Artificial intelligence for binary dental caries diagnosis using intraoral images and dental radiographs: a systematic review and meta-analysis - PMC
- Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions | FDA
Based on findings from:
Solventum Names Parag Kachalia Global Clinical Evidence Director
News Staff. Inside Dentistry, 2026.
https://insidedentistry.net/news?newsID=106790
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
